Long-term Efficacy and Safety of Photobiomodulation in Dry Age-Related Macular Degeneration (LIGHTSITE III: 24-Month Analysis)

Key Points

• This research aims to evaluate the long-term efficacy and safety of photobiomodulation in treating dry age-related macular degeneration.
• Used multiwavelength photobiomodulation as an intervention
• Analyzed participants over a 24-month period
• Evaluated visual function and safety outcomes
• Photobiomodulation significantly restored visual function
• Indicated potential disease-modifying effects in dry AMD
• Safety profile remained stable over the 24 months

Abstract